Bronchiectasis clinical trials at UCSF
1 research study open to eligible people
Showing trials for
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
open to eligible people ages 18-85
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Fresno 5350937, California 5332921 and other locations
Our lead scientists for Bronchiectasis research studies include Catherine Devoe, MD Mohamed Fayed, MD, FCCP.
Last updated: